(S)-2-Amino-N-cyclopropyl-N-(2,5-dichlorobenzyl)-3-methylbutanamide

Catalog No.: 
ACBIXK351
CAS No.: 
1354015-21-6
Molecular Formula: 
C15H20Cl2N2O
Molecular Weight: 
315.24
(S)-2-Amino-N-cyclopropyl-N-(2,5-dichlorobenzyl)-3-methylbutanamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$220.00InquiryInquiry
250mg97%$426.00InquiryInquiry
1g97%$1281.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-Amino-N-cyclopropyl-N-(2,5-dichlorobenzyl)-3-methylbutanamide
IUPAC Name(S)-2-amino-N-cyclopropyl-N-(2,5-dichlorobenzyl)-3-methylbutanamide
MDL No.MFCD21096946
Molecular FormulaC15H20Cl2N2O
Molecular Weight315.24
SMILESCC(C)[C@H](N)C(N(C1CC1)CC2=CC(Cl)=CC=C2Cl)=O
InChI KeyWBYIYHKVNXGGFI-AWEZNQCLSA-N
Synonym(S)-2-AMino-N-cyclopropyl-N-(2,5-dichloro-benzyl)-3-Methyl-butyraMide;Butanamide, 2-amino-N-cyclopropyl-N-[(2,5-dichlorophenyl)methyl]-3-methyl-, (2S)-
CAS No.1354015-21-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACBIXK351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBIXK351 route product structure diagram
    ACBIXK3511354015-21-6
Inquiry

2. ACBIXK351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBIXK351 route product structure diagram
    ACBIXK3511354015-21-6
Inquiry

3. ACBIXK351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBIXK351 route product structure diagram
    ACBIXK3511354015-21-6
Inquiry

Comments (0)